December 3, 2012 9:06 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Medtronic, Inc. (NYSE: MDT) today announced CE(Conformité Européenne) Mark approval of its innovative Sentrino® ContinuousGlucose Management System, the first minimally invasive continuous glucosemonitoring (CGM) system specifically designed for use in hospital criticalcare units (CCU). The Sentrino CGM System provides real-time trend data thatserves as an early warning system, allowing clinicians to appropriatelyintervene to prevent glycemic excursions and maximize the patient's time inthe target range. In addition, the system integrates simply into the clinicalworkflow in the hospital to improve the quality and efficiency of maintainingglucose control.Improved glucose management in critical care patients may reduce morbidity,mortality and the length of stay.^1-3 While glucose control is a standardpractice for diabetic and non-diabetic patients in the CCU, it's difficult toachieve. The Sentrino CGM System and the trending data it provides helpoptimize glucose management practices. Sentrino is an investigational deviceonly in the US and not approved for sale in the US.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.